Literature DB >> 32896227

How Clinically Relevant Is C-Reactive Protein for Blacks with Metabolic Syndrome to Predict Microalbuminuria?

Satyesh K Sinha1,2, Magda Shaheen1,2, Vikash R Singh3, Tripathi B Rajavashisth1,4, Deyu Pan2, Ling Sun5, Keith C Norris1, Susanne B Nicholas1.   

Abstract

Background: The metabolic syndrome (MetS) is associated with elevated urinary albumin (UA) excretion and C-reactive protein (CRP). However, potential differences in CRP levels on the association between individual components of the MetS and microalbuminuria (MA; 30-300 μg/mL) and/or UA (0-300 μg/mL) by race/ethnicity is unknown.
Methods: We analyzed National Health and Nutrition Examination Surveys (NHANES) data, (1999-2010) for adults (≥20 years of age) with the MetS (N = 5700). The Sobel-Goodman mediation test examined the influence of CRP on the association between individual MetS components and both MA and UA by race/ethnicity. We applied machine learning models to predict UA.
Results: CRP mediated the association between waist circumference (WC) and MA in Whites and Hispanics but not in Blacks. However, in general, the proportion of the total effect of MetS components on UA, mediated by CRP, was: 11% for high-density lipoprotein cholesterol (HDL-C) and 40% for WC (P < 0.001). In contrast to MA, the mediation effect of CRP for WC and UA was highest for Blacks (94%) compared with Whites (55%) or Hispanics (18%), P < 0.05. The prediction of an elevated UA concentration was increased in Blacks (∼51%) with the MetS when CRP was added to the random forest model. Conclusions: CRP mediates the association between UA and both HDL-C and WC in Whites and Blacks and between UA and WC in Hispanics. Moreover, the machine learning approach suggests that the incorporation of CRP may improve model prediction of UA in Blacks. These findings may favor screening for CRP in persons with the MetS, particularly in Blacks.

Entities:  

Keywords:  CRP; ethnicity; metabolic syndrome; race; urinary albumin

Mesh:

Substances:

Year:  2020        PMID: 32896227      PMCID: PMC7891189          DOI: 10.1089/met.2019.0121

Source DB:  PubMed          Journal:  Metab Syndr Relat Disord        ISSN: 1540-4196            Impact factor:   2.363


  44 in total

Review 1.  Uric acid as a mediator of diabetic nephropathy.

Authors:  Diana I Jalal; David M Maahs; Peter Hovind; Takahiko Nakagawa
Journal:  Semin Nephrol       Date:  2011-09       Impact factor: 5.299

2.  Markers of adipose tissue macrophage content are negatively associated with serum HDL-C concentrations.

Authors:  Jianying He; Xiaoyuan Xu; Ann Francisco; Anthony Ferrante; Jonathan Krakoff
Journal:  Atherosclerosis       Date:  2010-12-23       Impact factor: 5.162

3.  Low levels of urinary albumin excretion are associated with cardiovascular risk factors in the general population.

Authors:  W M Janssen; H Hillege; S J Pinto-Sietsma; A A Bak; D De Zeeuw; P E de Jong
Journal:  Clin Chem Lab Med       Date:  2000-11       Impact factor: 3.694

4.  Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study.

Authors:  Johan Arnlöv; Jane C Evans; James B Meigs; Thomas J Wang; Caroline S Fox; Daniel Levy; Emelia J Benjamin; Ralph B D'Agostino; Ramachandran S Vasan
Journal:  Circulation       Date:  2005-08-08       Impact factor: 29.690

5.  Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study.

Authors:  Anoop Shankar; Liping Sun; Barbara E K Klein; Kristine E Lee; Paul Muntner; F Javier Nieto; Michael Y Tsai; Karen J Cruickshanks; Carla R Schubert; Peter C Brazy; Josef Coresh; Ronald Klein
Journal:  Kidney Int       Date:  2011-08-24       Impact factor: 10.612

6.  Association between microalbuminuria and the metabolic syndrome: NHANES III.

Authors:  Latha Palaniappan; Mercedes Carnethon; Stephen P Fortmann
Journal:  Am J Hypertens       Date:  2003-11       Impact factor: 2.689

7.  Microalbuminuria and the metabolic syndrome and its components in the Chinese population.

Authors:  C-C Lin; C-S Liu; T-C Li; C-C Chen; C-I Li; W-Y Lin
Journal:  Eur J Clin Invest       Date:  2007-10       Impact factor: 4.686

8.  The expression of ATP-binding cassette transporter A1 in Chinese overweight and obese patients.

Authors:  M Xu; H Zhou; J Wang; C Li; Y Yu
Journal:  Int J Obes (Lond)       Date:  2009-06-16       Impact factor: 5.095

9.  Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey.

Authors:  Josef Coresh; Brad C Astor; Tom Greene; Garabed Eknoyan; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2003-01       Impact factor: 8.860

10.  The association of chronic kidney disease and metabolic syndrome with incident cardiovascular events: multiethnic study of atherosclerosis.

Authors:  Subhashish Agarwal; Michael G Shlipak; Holly Kramer; Aditya Jain; David M Herrington
Journal:  Cardiol Res Pract       Date:  2011-07-26       Impact factor: 1.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.